The advantages of nanomedicine in the treatment of visceral leishmaniasis: between sound arguments and wishful thinking-Reference-Cited by-同舟云学术

The advantages of nanomedicine in the treatment of visceral leishmaniasis: between sound arguments and wishful thinking

Published:2020-12-14 Issue:4 Volume:18 Page:471-487
ISSN:1742-5247
Container-title:Expert Opinion on Drug Delivery
language:en
Short-container-title:Expert Opinion on Drug Delivery

Author:

Matha Kevin¹²^ORCID,Calvignac Brice¹,Gangneux Jean-Pierre³⁴,Benoit Jean-Pierre¹²

Affiliation:

1. MINT, Univ Angers, INSERM 1066, CNRS 6021, Université Bretagne Loire, 4 Rue Larrey 49933 Angers cedex 9, France

2. CHU Angers, département Pharmacie,4 rue Larrey, 49933 Angers cedex 9, France

3. Univ Rennes, CHU Rennes, Inserm, EHESP, Irset , (Institut de recherche en santé, environnement et travail) - UMR_S 1085, F-35000 Rennes, France

4. Laboratoire de Parasitologie-Mycologie, CHU de Rennes, 2 rue Henri Le Guilloux, 35033, Rennes, France

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425247.2021.1853701

Reference176 articles.

1. Leishmaniasis

2. WHO Expert Committee on the Control of the Leishmaniases & World Health Organization. Control of the leishmaniases: report of a meeting of the WHO Expert Commitee on the Control of Leishmaniases, Geneva, 22-26 March 2010. World Health Organization; 2010. https://apps.who.int/iris/handle/10665/44412 (Accessed 09 August 2020)

3. Atypical Manifestations of Cutaneous Leishmaniasis in a Region Endemic for Leishmania braziliensis: Clinical, Immunological and Parasitological Aspects

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness In Vivo and In Vitro of Polymeric Nanoparticles as a Drug Release System in the Treatment of Leishmaniasis;Current Medicinal Chemistry;2024-01

2. Edible plant-derived nanotherapeutics and nanocarriers: recent progress and future directions;Expert Opinion on Drug Delivery;2022-03-25